The effect of dose and type of proton pump inhibitor u se on risk of fractures and osteoporosis treatment in older Australi an women: A prospective cohort study Annora Rizky Amalia (SBF201840441)
Fitrah Shafran I (SBF201840445)
Eka Oktafiani (SBF201840442)
Rikad Katon M (SBF201840451)
Eka Paramita H (SBF201840443)
Siti Mardhiyah (SBF201840455)
Did the study address a clearly focused issue?
Was the cohort recruited in an acceptable way?
Was the exposure accurately measured to minimise bias?
Was the outcome accurately measured to minimise bias?
Have the authors identified all important confounding factors?
Was the follow up of subjects complete enough ?